Same old outdated information. Good news is that upon conclusion of the CD-12 Trial, it may catch some off guard, maybe preventing some interference. Also, not sure why the summary does not list that it is a Phase 2b/3 Registrational Trial, as they do list 2/3 for others, just not us. Only mentioned in the very outdated notes that it is a Phase 2b/3 trial.